(lp0
S"Momenta Pharmaceuticals, Inc. Earnings Take a Back Seat Motley Fool - Feb 22, 2017 Momenta Pharmaceuticals  reported fourth-quarter earnings on Tuesday, but analysts weren't discussing the numbers.Momenta Delay Means Race For Copaxone Generic Is On - Seeking Alpha"
p1
aS'Why Momenta Pharmaceuticals, Inc. Jumped Higher Today Motley Fool - Oct 11, 2016 Before then, it seems likely Momenta will try and partner M923 . Last month, Momenta announced that it will regain rights to the drug from Shire.Momenta Pharmaceuticals  Stock Surges, Barclays Upgrades - TheStreet.com'
p2
aS'Why Momenta Pharmaceuticals, Inc. Stock Skyrocketed Higher Today Motley Fool - Jan 31, 2017 Shares of Momenta Pharmaceuticals  are up over 20% at 12:28 p.m. EST after the company announced that the U.S.Momenta Continues To Have A Lot Of Upside - Seeking Alpha'
p3
aS'Momenta Pharmaceuticals Appoints Scott M. Storer as Senior Vice President and ... GlobeNewswire  - Nov 2, 2016 CAMBRIDGE, Mass., Nov. 02, 2016  -- Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of Scott M.Mylan, Momenta move ahead in trial for rheumatoid arthritis drug - Pittsburgh Business Times'
p4
aS"Momenta Pharmaceuticals, Inc.: Good News from Courts and the FDA Ahead? Motley Fool - Aug 9, 2016 While the report included sales of Momenta's and partner Novartis AG's  Glatopa, the generic version of Teva Pharmaceutical Industries'  once-daily Copaxone, investors should focus on the potential approval of the generic&nbsp;..."
p5
aS"Momenta Pharma shares halted as drug application hits speed bump MarketWatch - Feb 17, 2017 Momenta Pharmaceuticals Inc. MNTA, +0.00% were halted in the extended session Friday after the biotech company said a supplier's compliance issue could delay approval of a higher dose of one of its multiple sclerosis drugs.Momenta halted after noting compliance issue in drug application - Seeking Alpha"
p6
aS'A Somewhat Murky Outlook For Momenta Pharmaceuticals Seeking Alpha - Dec 28, 2016 Although I have made some good gains from Momenta Pharmaceuticals over the past few months, it is one of the murkiest companies I follow in the biotech space.'
p7
aS'Russell Investments Group Ltd. Invests $284000 in Momenta Pharmaceuticals, Inc ... Markets Daily - 22 hours ago Momenta Pharmaceuticals logo Russell Investments Group Ltd. purchased a new position in Momenta Pharmaceuticals, Inc.  during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 18,948 shares of the&nbsp;...Momenta Pharmaceuticals, Inc.  held by 34 SEC 13F Filers - Post AnalystState Street Corp Has $28.266 Million Position in Momenta Pharmaceuticals, Inc ... - BBNS'
p8
aS'Momenta Pharmaceuticals Appoints Corey N. Fishman to Board of Directors GlobeNewswire  - Sep 23, 2016 CAMBRIDGE, Mass., Sept. 23, 2016  -- Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of Corey N.'
p9
aS'Momenta Pharmaceuticals Announces Publication on the Design of M230, a Novel ... GlobeNewswire  - Nov 17, 2016 CAMBRIDGE, Mass., Nov. 17, 2016  -- Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that data from preclinical&nbsp;...'
p10
a.